Skip to main content

Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies

Publication ,  Journal Article
Mesa, RA; Kiladjian, J-J; Verstovsek, S; Al-Ali, HK; Gotlib, J; Gisslinger, H; Levy, R; Siulnik, A; Gupta, V; Khan, M; DiPersio, JF; Knoops, L ...
Published in: Haematologica
2014

Duke Scholars

Published In

Haematologica

EISSN

1592-8721

ISSN

0390-6078

Publication Date

2014

Volume

99

Issue

2

Start / End Page

291 / 298

Related Subject Headings

  • Immunology
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mesa, R. A., Kiladjian, J.-J., Verstovsek, S., Al-Ali, H. K., Gotlib, J., Gisslinger, H., … Harrison, C. (2014). Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies. Haematologica, 99(2), 291–298.
Mesa, R. A., J. -. J. Kiladjian, S. Verstovsek, H. K. Al-Ali, J. Gotlib, H. Gisslinger, R. Levy, et al. “Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies.” Haematologica 99, no. 2 (2014): 291–98.
Mesa RA, Kiladjian J-J, Verstovsek S, Al-Ali HK, Gotlib J, Gisslinger H, et al. Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies. Haematologica. 2014;99(2):291–8.
Mesa, R. A., et al. “Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies.” Haematologica, vol. 99, no. 2, 2014, pp. 291–98.
Mesa RA, Kiladjian J-J, Verstovsek S, Al-Ali HK, Gotlib J, Gisslinger H, Levy R, Siulnik A, Gupta V, Khan M, DiPersio JF, McQuitty M, Catalano JV, Hunter DS, Knoops L, Deininger M, Cervantes F, Miller C, Vannucchi AM, Silver RT, Barbui T, Talpaz M, Barosi G, Winton EF, Mendeson E, Harvey Jr JH, Arcasoy MO, Hexner E, Lyons RM, Paquette R, Raza A, Sun W, Sandor V, Kantarjian HM, Harrison C. Comparison of placebo and best available therapy for the treatment of myelofibrosis in the phase 3 COMFORT studies. Haematologica. 2014;99(2):291–298.

Published In

Haematologica

EISSN

1592-8721

ISSN

0390-6078

Publication Date

2014

Volume

99

Issue

2

Start / End Page

291 / 298

Related Subject Headings

  • Immunology
  • 1102 Cardiorespiratory Medicine and Haematology